May 2, 2013 | envita.com
Epstein-Barr (EBV), also known as HHV-4, is a common human herpes virus that will infect virtually everyone on the planet at some point in their lifetimes. It is possible for EBV to remain dormant in the body throughout the...
Read more...
EBV Epstein-Barr Envita MS virus Lyme mononucleosis disease immune chronic fatigue
May 2, 2013 | envita.com
The importance of the immune system in fighting cancer was recognized as far back as the 1970s. It is important to see how the immune system and its components enhance a patient’s ability to fight back and how it may augment...
Read more...
immunotherapy immune cancer cytokines Envita cell treatment patient system AAIT cytokine
May 2, 2013 | bcm.edu
Dr. Meenakshi Hegde, a researcher and instructor of pediatrics at Baylor College of Medicine, received a $100,000 grant from CureSearch for Children's Cancer to study how the immune system can be harnessed to develop new...
Read more...
Dana Benson osteosarcoma CureSearch treatment Hegde research immunotherapy fund cancer Children study
May 2, 2013 | envita.com
One of the most frequent mistakes notably affecting stage 4 colon cancer patients is directly related to using standardized chemotherapy protocols. The approach is widely inappropriate, because ultimately, it’s only 2%...
Read more...
colon cancer AAIT treatment stage 4 patient chemotherapy cell
May 2, 2013 | prweb.com
As the Pacific Northwest region heads into record temperatures this weekend, Cancer Treatment Centers of America® (CTCA) at Western Regional Medical Center (Western) reminds Oregonians and Washingtonians that it is important to...
Read more...
o CTCA sun cancer skin mole Washingtonian treatment exposure Oregonian tip patient
May 2, 2013 | envita.com
AAIT was developed in 2006 and may be used to fight against numerous cancers, possibly helping as a treatment for cancer and metastatic cancers. Since AAIT has yet to be approved by the FDA, it is currently only available in...
Read more...
All similar articles: 195 »
cancer immunotherapy immune treatment AAIT Hermosillo www.envitamexico.mx Immuno-cell metastatic system Envita tumor Interleukin
May 3, 2013 | drugs.com
Imaging Studies Show Docetaxel Strongly Upregulates Bavituximab's PS Target in Tumors, Further Supporting Lead Clinical Indication in Second Line Non-Small Cell Lung Cancer; Preclinical Studies Support Potential of Bavituximab...
Read more...
Peregrine tumor AACR PS bavituximab NSCLC clinical antibody cancer PS-targeting immune trial Phase betabodies phosphatidylserine PS-binding second-line preclinical Pharmaceuticals cell data
May 2, 2013 | envita.com
First reported in 1986, human herpesvirus 6 (HHV-6) has since become one of the most widespread members of human herpes viruses and comes in two related variants: HHV-6A and HHV-6B. Though nearly identical, there are...
Read more...
HHV-6 Lyme Chronic Disease Viral infection CFS virus
May 2, 2013 | envita.com
Immunology Strengthens Fight Against Stage 4 Cancer and Stage 4 Leukemia The field of cancer immunology is now more than 30 years old and has developed rapidly, particularly over the last 10 years. Immunotherapy, the use of the...
Read more...
immunotherapy www.envitamexico.mx Leukemia immunology Stage cancer immune disease-fighting Strengthens stimulated Hermosillo white blood cell monoclonal
May 3, 2013 | drugs.com
A $4-million public-private partnership will promote research innovation involving three academic commercialization centres in Canada CHICAGO, ILLINOIS, April 22, 2013 /CNW Telbec/ - Merck Canada will be announcing today at the...
Read more...
IRICoR Merck CDRD commercialization research MaRS Quebec Innovation Ontario
May 2, 2013 | fortmilltimes.com
Mentor Capital, Inc. (Pink Sheets:MNTR) reports that its proprietary Cancer Immunotherapy Index appreciated 28.0% during the first quarter of 2013. The equally weighted Cancer Immunotherapy Index is regularly benchmarked...
Read more...
Mentor Immunotherapy Cancer Celldex Index 2013 Immunocellular gain Advaxis quarter Vical Therapeutics Pink Million Dendreon
May 2, 2013 | envita.com
The field of cancer immunology is ostensibly greater than 30 years old and has developed with fervor, particularly over the last 10 years. Immunotherapy, the management of the stimulated immune system to ward off disease, has...
Read more...
immunotherapy cancer stage breast 4 treatment www.envitamexico.mx
May 1, 2013 | envita.com
Metastasis refers to the spread of cancer cells from a primary tumor to distant sites in the body. It is one of the most devastating aspects of cancer, and it accounts for over 90 percent of cancer patient deaths. An area of...
Read more...
cancer cell metastasis tumor dormant immune immunity patient recurrence Cytokines metastasized dormancy
May 1, 2013 | envita.com
Inflammation is the body’s response to tissue damage, caused by physical injury, ischemic injury (caused by an insufficient supply of blood to an organ), infection, exposure to toxins, or other types of trauma. The body’s...
Read more...
inflammation cancer Envita chronic cell cellular mutation treatment proliferation DNA tumor tissue
May 1, 2013 | envita.com
One in two men and one in three women in the U.S. will develop cancer in their lifetime. Of all those cases, less than 5 percent will present as genetically related. So, what are the causes of the remaining 95 percent? Toxins...
Read more...
cancer infection toxin carcinogen water 23558785 substance immune Envita cause exposure Epigenetic pesticide www.msnbc.msn.com food
May 2, 2013 | bdaily.co.uk
Liverpool-based firm Redx Pharma has signed a deal with Canadian company Pharmascience, which will give them the rights to develop a promising anti-cancer programme. Research will be carried out by Redx’s spin-out business,...
Read more...
Miranda Dobson Redx Pharmascience anti-cancer cFMS cancer Canadian secure deal CFS-1R immune research
May 1, 2013 | sandiegonewscape.com
San Diego, California (NAPSI) - Cancer is one of the most widespread diseases and the leading cause of death worldwide. Nearly one in 24 Americans are living with some form of cancer, so chances are you know someone with the...
Read more...
Yervoy o melanoma metastatic inflammation patient gland ipilimumab skin symptom lead to effect liver treatment side healthcare
May 2, 2013 | nih.gov
Changes in DNA that are important to the initiation and progression of lung cancer also identified by NIH-supported researchers Histological tissue section from a sample of lung squamous carcinoma. Researchers have identified...
Read more...
squamous squamose TCGA lung carcinoma cancer cell therapeutic tumor researcher adenocarcinomas NHGRI gene NIH genome mutation
May 1, 2013 | newsmark.biz
Can patterns in tree branches or the meandering bends in a river provide clues that could lead to better cancer therapies? According to a new study, these self-similar, repeating patterns in nature known as fractals help...
Read more...
immune cancer nature understand system transplant self-similar fractals pattern meandering leukemia
May 1, 2013 | insidermonkey.com
Three biotech companies are making themselves heard in the stock market. They are making a mark in the life sciences space with their unique mix of science and strategy. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) is on the...
Read more...
Ariad Celldex aria drug Inc. NASDAQ:CLDX NASDAQ:ARIA disease cancer Biopharma Therapeutics NASDAQ:ARRY Iclusig Pharmaceuticals pharma
May 1, 2013 | mercola.com
I've sprouted seeds on and off over the years, mostly a mixed blend of seeds. I usually keep "kitty" grass growing for the pets. What I didn't realize is the benefits from sprouting sunflower seeds. Bought some sunflower seeds...
Read more...
ILCs leafy T-bet vegetable Green eat bacterium digestive cell gene essential gut immune food diet interleukin-22
Apr 30, 2013 | dddmag.com
One in five individuals is likely to suffer from skin cancer at some point in their lives, and the numbers are steadily increasing. Despite advances that have been made in sunscreen technology and growing public awareness of...
Read more...
All similar articles: 509 »
cancer OncoSec ImmunoPulse treatment skin melanoma tumor OMS cell therapy immunotherapy patient BRAF-mutant Medical locoregional
Apr 30, 2013 | pmlive.com
Drug development for this type of bone marrow cancer has been gaining momentum, with two new proteasome inhibitor approvals in the last year alone and a number of new treatments in late-stage pipeline
Read more...
myeloma dexamethasone lenalidomide bortezomib multiple therapy thalidomide cell panobinostat patient relapsed inhibitor agent combination refractory phase proteasome trial
Apr 30, 2013 | onclive.com
Published Online: Tuesday, April 30, 2013 Studies that continue to shed light on the optimal use of sipuleucel- T in men with prostate cancer were presented at the 2013 Genitourinary Cancers Symposium. Sipuleucel-T, the...
Read more...
Sipuleucel-T patient TFOA PROCEED docetaxel sipuleucel vaccine prostate docetaxel-naïve placebo mCRPC
May 1, 2013 | searchitup.com
by Frank Hamm Berkeley, CA (PRWEB) December 19, 2012 Now in its tenth year as an online urology-medical oncology publisher, Digital Science Press, Inc. (DSP) — UroToday.com is expanding key prostate cancer content with two new...
Read more...
UroToday prostate metastatic cancer MD immunotherapy urology mCRPC UroToday.com Carithers
May 1, 2013 | guardian.co.uk
Two companies will link up in immunotherapy programme to treat cancer cells Oxford BioMedica is one of the day's best performers so far after the group unveiled a collaboration with Swiss pharmaceutical group Novartis to work...
Read more...
All similar articles: 82 »
Nick Fletcher Novartis Oxford BioMedica Lentivector collaboration Retinostat cell immunotherapy
May 1, 2013 | checkorphan.org
Can the patterns in tree branches or the meandering bends in a river provide clues that could lead to better cancer therapiesAccording to a new study from Virginia Commonwealth University Massey Cancer Center, these...
Read more...
cell T Toor receptor transplant immune VCU stem Massey repertoire fractal Ph.D. researcher transplantation segment cancer
Apr 30, 2013 | thedoctorschannel.com
By Megan Brooks NEW YORK (Reuters Health) – Two doses of human papillomavirus (HPV) vaccine in young girls may be as immunogenic as three doses in young women, although the duration of protection may be less, Canadian...
Read more...
All similar articles: 98 »
Megan Brooks dose HPV vaccine girl HPV-6 Dobson noninferiority JAMA study HPV-related reduced-dose antibody receive Dr. genotype HPV-18
May 1, 2013 | the-scientist.com
Research Associate, Perelman School of Medicine, University of Pennsylvania. Age: 27 By Dan Cossins | May 1, 2013 Interested in medicine, Sonnenberg volunteered at a local hospital, but he was also accepted into the lab of...
Read more...
Dan Cossins Sonnenberg ILCs Alcaligenes IL-22 inflammatory Bankert bacterium commensal mouse chronic lymphoid
May 1, 2013 | sciencenet.cn
News from the National Academy of SciencesDate: April 30, 2013FOR IMMEDIATE RELEASENational Academy of Sciences Members and Foreign Associates ElectedThe National Academy of Sciences announced today the election of 84 new...
Read more...
department Professor University Institute mathematics physic molecular Medical biology chemistry School Medicine University of California science